首页> 外文期刊>Annals of Saudi medicine. >Incidence and prognosis of stent thrombosis following percutaneous coronary intervention in Middle Eastern patients: The First Jordanian Percutaneous Coronary Intervention Registry (JoPCR1)
【24h】

Incidence and prognosis of stent thrombosis following percutaneous coronary intervention in Middle Eastern patients: The First Jordanian Percutaneous Coronary Intervention Registry (JoPCR1)

机译:中东患者经皮冠状动脉介入治疗后支架血栓的发生率和预后:第一个约旦人经皮冠状动脉介入治疗注册系统(JoPCR1)

获取原文
           

摘要

BACKGROUND: The incidence, risk factors, and outcome of stent thrombosis (ST) after percutaneous coro.nary intervention (PCI) in Middle Eastern patients are largely unknown. OBJECTIVE: To determine the incidence, risk factors and outcome in our population. DESIGN: Retrospective study of a prospective multicenter registry of consecutive patients who underwent PCI between January 2013 and February 2014 (JoPCR1). SETTING: 12 tertiary care centers in Amman and Irbid, Jordan. PATIENTS AND METHODS: We collected clinical baseline and follow-up data. MAIN OUTCOME MEASURES: Incidence of stent thrombosis. RESULTS: The mean (standard deviation) age of patients (n=2426) was 59.0 (10.1) years and 20.6% were women. Stents (n=3038) were drug eluting (89.6%), bare metal (9.4%) or bioabsorbable (1.0%). After 1 year, 47 patients (1.97%) had ST, including 44 (94%) definite and 3 (6%) probable ST. Patients who had ST presented with sudden death (n=6; 12.2%) or with a nonfatal event (n=43; 87.8%). Nonfatal events included non-ST-segment elevation acute coronary syndrome (26; 53%), acute ST segment elevation myocardial infarction (n=15; 31%) or heart failure (n=2; 4.1%). ST was associated with significantly higher one-month (22.0% vs. 0.7%) and one-year (12.3% vs. 0.73%) mortality rates compared with patients who did not have ST ( P CONCLUSIONS: The incidence of ST was not different from that in other regions and was associated with an increased one-year mortality. Younger age, heart failure, low LVEF, ST-segment deviation, and elevated blood levels of cardiac biomarkers were predictors of ST. LIMITATIONS: Possible selection bias, recall bias, and missing or incomplete information. The majority of patients were lost to follow up after the 6th month. The registry may not fully represent PCI practice and outcome in all areas in the country or region.
机译:背景:中东患者经皮冠状动脉介入治疗(PCI)后发生支架血栓形成(ST)的发生率,危险因素和结果尚不清楚。目的:确定我国人群的发病率,危险因素和结果。设计:对2013年1月至2014年2月间接受PCI的连续患者的前瞻性多中心登记进行回顾性研究(JoPCR1)。地点:约旦安曼和伊尔比德的12个三级护理中心。患者和方法:我们收集了临床基线和随访数据。主要观察指标:支架内血栓形成发生率。结果:患者(n = 2426)的平均年龄(标准差)为59.0(10.1)岁,女性为20.6%。支架(n = 3038)为药物洗脱(89.6%),裸金属(9.4%)或可生物吸收(1.0%)。一年后,有47例(1.97%)的ST患者,包括44例(94%)明确的ST和3例(6%)可能的ST。患有ST的患者表现为猝死(n = 6; 12.2%)或非致命事件(n = 43; 87.8%)。非致命事件包括非ST段抬高的急性冠状动脉综合征(26; 53%),急性ST段抬高的心肌梗塞(n = 15; 31%)或心力衰竭(n = 2; 4.1%)。与没有ST的患者相比,ST与1个月(22.0%vs. 0.7%)和1年(12.3%vs. 0.73%)的死亡率显着相关(结论:ST的发生率没有差异年龄,心力衰竭,LVEF低,ST段偏差和心脏生物标志物血液水平升高是ST的预测指标。以及缺少或不完整的信息;大多数患者在第6个月后就失去了随访;注册表可能无法完全代表该国家或地区在所有地区的PCI实践和结果。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号